Quentin McCubbin, PhD, joined Frequency Therapeutics in January 2021 as Chief Manufacturing Officer. In this role, he oversees technical operations, leading overall efforts in drug product formulation, chemistry manufacturing and controls (CMC) and supply chain to support the development of Frequency’s pipeline of product candidates.

Dr. McCubbin joined Frequency from Cerevel Therapeutics, a clinical-stage biotechnology company where he served as Head of Technical Operations for two years. Prior to Cerevel, he spent 19 years at Takeda/Millennium Pharmaceuticals in variety of roles including six years as Vice President of Pharmaceutical Sciences and Global Head of Process Chemistry. He began his career as a chemist, completing a post-doctoral fellowship at Imperial College in London. He earned his B.S. and Ph.D. in Chemistry from Monash University in Australia. He is an inventor on several patents and has published numerous peer-reviewed articles.